HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

TAMBRANDS NEW PRESIDENT, CEO EDWARD FOGARTY

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

TAMBRANDS NEW PRESIDENT, CEO EDWARD FOGARTY is joining May 31 from Colgate-Palmolive, where he was president of the firm's U.S., Canada and Puerto Rico operations. Tambrands Chairman Howard Wentz has been performing the duties of CEO since June, when Martin Emmett resigned as chairman and CEO. The president's post had been vacant since June, when then-President Charles Chapman's title was changed to exec VP and president of the North American division under a restructuring.

Table

View full table

Tags:
Latest Headlines

US Consumer Health Market People News: Herbalife, Seed Health, Electrolit, Atlas Bars, More

US Women’s Health Sector: Hip Hop Stars Invest In Proov, Good Clean Love Names CEO

Reckitt Sees R&D Investment Translate To Volume Growth

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

See All
UsernamePublicRestriction

Register

RS000418

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By